Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/65614Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ranganath, P L N | - |
| dc.contributor.author | Annapurna, K | - |
| dc.contributor.author | Anil, T | - |
| dc.contributor.author | Narsaiah, A Venkat | - |
| dc.date.accessioned | 2025-03-28T09:06:26Z | - |
| dc.date.available | 2025-03-28T09:06:26Z | - |
| dc.date.issued | 2025-03 | - |
| dc.identifier.issn | ISSN: 2583-1321 (Online);ISSN: 0019-5103 (Print) | - |
| dc.identifier.uri | http://nopr.niscpr.res.in/handle/123456789/65614 | - |
| dc.description | 285-290 | en_US |
| dc.description.abstract | 1,2,3-Triazole scaffolds are playing a vital role in various fields. These are not natural products but produced by synthetic chemists. Isafroxadin natural product and its 1,2,3-triazole derivatives have been synthesized using Click protocol. Thus, the newly generated scaffolds have been subjected to docking studies against inflammatory and tuberculosis activity. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | NIScPR-CSIR, India | en_US |
| dc.source | IJC Vol.64(03) [March 2025] | en_US |
| dc.subject | Isofroxadin | en_US |
| dc.subject | Triazoles | en_US |
| dc.subject | Click reaction | en_US |
| dc.subject | Inflammatory | en_US |
| dc.subject | Tuberculosis | en_US |
| dc.title | Design and synthesis of novel triazole-isofroxadin molecules: Docking studies against inflammatory and tuberculosis targets | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | https://doi.org/10.56042/ijc.v64i3.16320 | en_US |
| Appears in Collections: | IJC Vol.64(03) [March 2025] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJC 64(3) 285-290.pdf | 4.9 MB | Adobe PDF | View/Open | |
| IJC 64(3) 285-290 Suppl. Data.pdf | 4.14 MB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.